HCWB
HCW Biologics Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
39
Buys
38
Sells
0
Largest Trade
$1M+
Insiders
6
Institutional Funds
8
Inst. Value
$50K–$100K
Activist Filings
3
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Wong Hing C | CEO | BUY | $50K–$100K | 8K | $7.45 | May 20, 2025 |
| Winer Gary M | Director | BUY | $1K–$15K | 1K | $7.45 | May 20, 2025 |
| GARRETT SCOTT T | Director | BUY | $100K–$500K | 13K | $7.45 | May 20, 2025 |
| Winer Gary M | Director | BUY | $50K–$100K | 2K | $26.00 | May 9, 2025 |
| Wong Hing C | CEO | BUY | $1M+ | 93K | $26.00 | May 9, 2025 |
| GARRETT SCOTT T | Director | BUY | $100K–$500K | 5K | $26.00 | May 9, 2025 |
| Byam Rebecca | CFO | BUY | $100K–$500K | 8K | $26.00 | May 9, 2025 |
| Flowers Lee | SVP of Business De… | BUY | $15K–$50K | 962 | $26.00 | May 9, 2025 |
| Greene Rick S. | Director | BUY | $15K–$50K | 962 | $26.00 | May 9, 2025 |
| Wong Hing C | CEO | BUY | $1K–$15K | 2K | $2.08 | Sep 18, 2023 |
| Winer Gary M | Director | BUY | $1K–$15K | 2K | $2.05 | Sep 15, 2023 |
| Byam Rebecca | CFO | BUY | $1K–$15K | 5K | $2.10 | Sep 15, 2023 |
| Byam Rebecca | CFO | BUY | $15K–$50K | 10K | $2.07 | Sep 13, 2023 |
| Winer Gary M | Director | BUY | $1K–$15K | 600 | $2.05 | Sep 13, 2023 |
| Byam Rebecca | CFO | BUY | $15K–$50K | 10K | $1.99 | Sep 8, 2023 |
| Winer Gary M | Director | BUY | <$1K | 463 | $1.78 | Sep 7, 2023 |
| Byam Rebecca | CFO | BUY | $1K–$15K | 5K | $1.95 | Sep 7, 2023 |
| Flowers Lee | SVP of Business De… | EXERCISE | <$1K | 5K | $0.14 | Jun 10, 2023 |
| Flowers Lee | SVP of Business De… | BUY | $15K–$50K | 10K | $2.16 | Jun 10, 2023 |
| Byam Rebecca | CFO | BUY | $15K–$50K | 20K | $2.06 | Jun 9, 2023 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 25K | $2.07 | Jun 8, 2023 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 39K | $1.74 | Jun 7, 2023 |
| Wong Hing C | CEO | BUY | $1K–$15K | 2K | $1.58 | Jun 3, 2023 |
| Wong Hing C | CEO | BUY | $1K–$15K | 5K | $1.55 | Jun 1, 2023 |
| Winer Gary M | Director | BUY | $1K–$15K | 1K | $1.51 | Jun 1, 2023 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 40K | $1.64 | May 31, 2023 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 58K | $1.56 | May 24, 2023 |
| Byam Rebecca | CFO | BUY | $15K–$50K | 15K | $2.58 | Sep 15, 2022 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 30K | $2.61 | Sep 14, 2022 |
| Wong Hing C | CEO | BUY | $15K–$50K | 10K | $2.69 | Sep 12, 2022 |
| Wong Hing C | CEO | BUY | $15K–$50K | 10K | $2.57 | Sep 7, 2022 |
| Byam Rebecca | CFO | BUY | $15K–$50K | 17K | $2.55 | Sep 1, 2022 |
| Byam Rebecca | CFO | BUY | $50K–$100K | 20K | $2.55 | Aug 30, 2022 |
| Byam Rebecca | CFO | BUY | $100K–$500K | 90K | $2.54 | Aug 26, 2022 |
| Byam Rebecca | CFO | BUY | $100K–$500K | 66K | $2.42 | Jun 15, 2022 |
| Wong Hing C | CEO | BUY | $1K–$15K | 2K | $2.19 | Jun 13, 2022 |
| Winer Gary M | Director | BUY | $1K–$15K | 4K | $2.19 | Jun 11, 2022 |
| Wong Hing C | CEO | BUY | $1K–$15K | 3K | $2.27 | Jun 9, 2022 |
| Winer Gary M | Director | BUY | $1K–$15K | 2K | $2.11 | Jun 8, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 8 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DRW Securities, LLC | 35K | $15K–$50K | SH |
| J.W. COLE ADVISORS, INC. | 13K | $1K–$15K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 11K | $1K–$15K | SH |
| Golden State Wealth Management, LLC | 10K | $1K–$15K | SH |
| VANGUARD GROUP INC | 2K | $1K–$15K | SH |
| UBS Group AG | 2K | $1K–$15K | SH |
| WELLS FARGO & COMPANY/MN | 1K | <$1K | SH |
| CITIGROUP INC | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 18, 2026
10.0%
401K shares
SC 13D/A · Jun 13, 2025
23.4%
502K shares
SC 13D/A · Nov 22, 2024
36.0%
16.1M shares